Thomayer's Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2009
NCT01038804
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Thomayer Faculty Hosptial L.G.

Active Ingredients

Drugs in Phase 2 Trials (3)

99mtc mip 1404 (1 trial)

docetaxel (taxotere) (1 trial)

sepantronium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3